Raj Kannan was named Chief Executive Officer in June 2019. Raj brings over 25 years of pharma industry experience. He has held a variety of roles from field sales to leading global business franchises.  Raj has led and supported multiple successful launches across therapeutic areas both in the US and globally. Prior to joining Chiasma, Raj served as the Chief Commercial Officer at Kiniksa Pharmaceuticals since July 2018. In that role, he was responsible for building and leading the company’s commercial operations, including sales, marketing, business analytics, and market access functions. Prior to Kiniksa, Raj served as the Global Head of the Neurology and Immunology business franchise at Merck KGaA, where he was responsible for $2 billion in annual revenues and for providing the strategic direction for assets in clinical development.  Prior to Merck KGaA, Raj spent ten years at Boehringer Ingelheim in roles of increasing responsibility in the US, Canada, and in Germany, including the role of Global Marketing Head of the Cardiovascular Franchise where he was responsible for over $3.5B in annual revenues.